These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25108120)

  • 1. The combination of strong immunohistochemical mtTFA expression and a high survivin index predicts a shorter disease-specific survival in pancreatic ductal adenocarcinoma.
    Kimura T; Kitada S; Uramoto H; Zhi L; Kawatsu Y; Takeda T; Horie S; Nabeshima A; Noguchi H; Sasaguri Y; Izumi H; Kohno K; Yamada S
    Histol Histopathol; 2015 Feb; 30(2):193-204. PubMed ID: 25108120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial transcription factor a worsens the clinical course of patients with pancreatic cancer through inhibition of apoptosis of cancer cells.
    Yamauchi M; Nakayama Y; Minagawa N; Torigoe T; Shibao K; Yamaguchi K
    Pancreas; 2014 Apr; 43(3):405-10. PubMed ID: 24622070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High nuclear Survivin expression as a poor prognostic marker in pancreatic ductal adenocarcinoma.
    Zhou L; Lu J; Liang ZY; Zhou WX; Yuan D; Li BQ; You L; Guo JC; Zhao YP
    J Surg Oncol; 2018 Dec; 118(7):1115-1121. PubMed ID: 30261114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin expression and serum levels in pancreatic cancer.
    Dong H; Qian D; Wang Y; Meng L; Chen D; Ji X; Feng W
    World J Surg Oncol; 2015 May; 13():189. PubMed ID: 26016480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of mitochondrial transcription factor A expression in patients with colorectal cancer.
    Nakayama Y; Yamauchi M; Minagawa N; Torigoe T; Izumi H; Kohno K; Yamaguchi K
    Oncol Rep; 2012 May; 27(5):1325-30. PubMed ID: 22266811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of Mitochondrial Transcription Factor A Expression in Patients with Right- or Left-sided Colorectal Cancer.
    Katsuki T; Nakayama Y; Akiyama M; Sawatsubashi Y; Nagata J; Minagawa N; Torigoe T; Izumi H; Kohono K; Hirata K
    Anticancer Res; 2018 Jan; 38(1):569-575. PubMed ID: 29277826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of a nuclear HMGB1-positive and HMGB2-negative expression is potentially associated with a shortened survival in patients with pancreatic ductal adenocarcinoma.
    Takeda T; Izumi H; Kitada S; Uramoto H; Tasaki T; Zhi L; Guo X; Kawatsu Y; Kimura T; Horie S; Nabeshima A; Noguchi H; Wang KY; Sasaguri Y; Kohno K; Yamada S
    Tumour Biol; 2014 Oct; 35(10):10555-69. PubMed ID: 25060178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis.
    Sun HC; Qiu ZJ; Liu J; Sun J; Jiang T; Huang KJ; Yao M; Huang C
    Int J Oncol; 2007 Jun; 30(6):1359-67. PubMed ID: 17487356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients.
    Tonini G; Vincenzi B; Santini D; Scarpa S; Vasaturo T; Malacrino C; Coppola R; Magistrelli P; Borzomati D; Baldi A; Antinori A; Caricato M; Nuzzo G; Picciocchi A
    Br J Cancer; 2005 Jun; 92(12):2225-32. PubMed ID: 15928668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BIRC7 and KLF4 expression in benign and malignant lesions of pancreas and their clinicopathological significance.
    Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
    Cancer Biomark; 2016; 17(4):437-444. PubMed ID: 27802195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased circadian component Bmal1 predicts tumor progression and poor prognosis in human pancreatic ductal adenocarcinoma.
    Li W; Liu L; Liu D; Jin S; Yang Y; Tang W; Gong L
    Biochem Biophys Res Commun; 2016 Mar; 472(1):156-62. PubMed ID: 26915801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of apoptotic activity, survivin, Ki-67, and P-glycoprotein expression on prognosis in pancreatic carcinoma.
    Sagol O; Yavuzsen T; Oztop I; Ulukus C; Ylmaz U; Alakavuklar M; Karademir S; Obuz F; Astarcoğlu H; Astarcoglu I
    Pancreas; 2005 May; 30(4):343-8. PubMed ID: 15841045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial transcription factor A regulates BCL2L1 gene expression and is a prognostic factor in serous ovarian cancer.
    Kurita T; Izumi H; Kagami S; Kawagoe T; Toki N; Matsuura Y; Hachisuga T; Kohno K
    Cancer Sci; 2012 Feb; 103(2):239-444. PubMed ID: 22098591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical usefulness of mitochondrial transcription factor A expression as a predictive marker in colorectal cancer patients treated with FOLFOX.
    Yoshida Y; Hasegawa J; Nezu R; Kim YK; Hirota M; Kawano K; Izumi H; Kohno K
    Cancer Sci; 2011 Mar; 102(3):578-82. PubMed ID: 21205083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of mitochondrial transcription factor A in endometrial carcinomas: clinicopathologic correlations and prognostic significance.
    Toki N; Kagami S; Kurita T; Kawagoe T; Matsuura Y; Hachisuga T; Matsuyama A; Hashimoto H; Izumi H; Kohno K
    Virchows Arch; 2010 Apr; 456(4):387-93. PubMed ID: 20232213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human mitochondrial transcription factor A functions in both nuclei and mitochondria and regulates cancer cell growth.
    Han B; Izumi H; Yasuniwa Y; Akiyama M; Yamaguchi T; Fujimoto N; Matsumoto T; Wu B; Tanimoto A; Sasaguri Y; Kohno K
    Biochem Biophys Res Commun; 2011 Apr; 408(1):45-51. PubMed ID: 21453679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin expression in pancreatic intraepithelial neoplasia (PanIN): steady increase along the developmental stages of pancreatic ductal adenocarcinoma.
    Bhanot U; Heydrich R; Möller P; Hasel C
    Am J Surg Pathol; 2006 Jun; 30(6):754-9. PubMed ID: 16723855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of Smac and survivin expression in breast cancer patients treated with anthracycline‑based neoadjuvant chemotherapy.
    Zhao YC; Wang Y; Ni XJ; Li Y; Wang XM; Zhu YY; Luo CY
    Mol Med Rep; 2014 Feb; 9(2):614-20. PubMed ID: 24317109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.